Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityBGB / Blackstone / GSO Strategic Credit Fund (09257R101)
Chairman and CEOSCHWARZMAN STEPHEN A
IndustryInvestment Advice
Institutional Owners57
Institutional Shares18,877,237 - 2.85%
Common Shares Outstanding661,530,630 shares (as of 2018-03-31)
Institutional Value$ 299,818,000 USD
Related BX / Blackstone Group L.P. (The)
00B1YWNW1 / Blackstone Group Lp/t Npv Bond
LSE:BGLF / BLACKSTONE / GSO LOAN FINANCING LTD
BGX / Blackstone / GSO Long-Short Credit Income Fund

Institutional Stock Ownership and Shareholders()

BGB / Blackstone / GSO Strategic Credit Fund Institutional Ownership

Blackstone / GSO Strategic Credit Fund (NYSE:BGB) has 57 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,877,237 shares. Largest shareholders include JP Morgan Chase & Co, LLBH Private Wealth Management, LLC, Bank Of America Corp /de/, Morgan Stanley, UBS Group AG, Oak Hill Advisors Lp, Guggenheim Capital Llc, Wells Fargo & Company/mn, Bessemer Group Inc, and Invesco Ltd..
Blackstone / GSO Strategic Credit Fund (NYSE:BGB) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/bgb"><img src="https://images.fintel.io/us-bgb-so.png" alt="BGB / Blackstone / GSO Strategic Credit Fund Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-14 13F-HR BB&T SECURITIES, LLC 61,324 54,816 -10.61 963 870 -9.66
2018-05-14 13F-HR Vident Investment Advisory, LLC 576,990 349,281 -39.46 9,065 5,564 -38.62
2018-05-02 13F-HR Greenwich Wealth Management LLC 37,301 37,301 0.00 586 592 1.02
2018-05-10 13F-HR TORON CAPITAL MARKETS INC. 27,443 27,443 0.00 431 532 23.43
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 255,286 238,551 -6.56 4,011 3,789 -5.53
2018-05-14 13F-HR SRS Capital Advisors, Inc. 320 0 -100.00 5 0 -100.00
2018-05-15 13F-HR LPL Financial LLC 18,774 15,336 -18.31 295 244 -17.29
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 877,505 845,329 -3.67 13,785 13,424 -2.62
2018-04-11 13F-HR Ruggie Capital Group 9,000 9,000 0.00 141 143 1.42
2018-05-15 13F-HR Invesco Ltd. 652,081 750,418 15.08 10,244 11,917 16.33
2018-05-03 13F-HR SG Americas Securities, LLC 41,500 0 -100.00 652 0 -100.00
2018-05-08 13F-HR Advisornet Financial, Inc 1,800 29
2018-05-10 13F-HR JP Morgan Chase & Co 2,836,877 2,895,524 2.07 44,568 45,981 3.17
2017-05-09 13F-HR LBA Wealth Management, LLC 2 2 0.00
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 70,491 54,373 -22.87 1,107 863 -22.04
2018-07-09 13F-HR Capital Investment Advisors, LLC 353,366 347,524 -1.65 5,611 5,494 -2.09
2018-04-23 13F-HR Selway Asset Management 108,525 107,335 -1.10 1,705 1,704 -0.06
2018-05-15 13F-HR Arete Wealth Advisors, LLC 44,608 52,504 17.70 701 834 18.97
2018-05-03 13F-HR Aviance Capital Partners, LLC 29,923 34,100 13.96 470 541 15.11
2018-05-08 13F-HR Wunderlich Capital Managemnt 9,727 10,593 8.90 153 168 9.80
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 992,935 999,114 0.62 15,599 15,866 1.71
2018-04-11 13F-HR Horrell Capital Management, Inc. 9,000 9,000 0.00 141 143 1.42
2018-07-17 13F-HR BAILLIE GIFFORD & CO 521,530 271,120 -48.01 8,282 4,286 -48.25
2018-05-08 13F-HR DOLIVER CAPITAL ADVISORS, INC. 11,904 0 -100.00 187 0 -100.00
2018-05-15 13F-HR RIVERNORTH CAPITAL MANAGEMENT, LLC 503,955 383,818 -23.84 7,917 6,095 -23.01
2018-07-16 13F-HR Live Your Vision, LLC 1,850 30
2018-05-15 13F-HR PATHSTONE FAMILY OFFICE, LLC 0 26 0 0
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 5,200 0 -100.00 82 0 -100.00
2018-05-10 13F-HR BESSEMER GROUP INC 829,686 799,186 -3.68 13,035 12,692 -2.63
2017-01-13 13F-HR MetLife Securities, Inc 6,721 6,721 0.00 100 103 3.00
2017-05-10 13F-HR Concert Wealth Management Inc. 10,619 10,619 0.00 162 162 0.00
2018-05-15 13F-HR OAK HILL ADVISORS LP 1,229,152 1,229,152 0.00 19,310 19,519 1.08
2017-07-17 13F-HR Wela Strategies, Inc. 56,077 893
2018-05-15 13F-HR FIFTH THIRD BANCORP 9 0 -100.00 0 0
2018-05-15 13F-HR YorkBridge Wealth Partners, LLC 2,970 2,970 0.00 46 47 2.17
2018-05-14 13F-HR Laurion Capital Management LP 100,384 38,841 -61.31 1,577 617 -60.88
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 28,839 33,737 16.98 453 535 18.10
2018-05-15 13F-HR ROBINSON CAPITAL MANAGEMENT, LLC 161,388 143,283 -11.22 2,535 2,277 -10.18
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 1,483,552 2,124,570 43.21 23,307 33,738 44.75
2018-04-18 13F-HR REGIONS FINANCIAL CORP 1,250 0 -100.00 20 0 -100.00
2018-05-11 13F-HR Relative Value Partners Group, LLC 38,902 0 -100.00 611 0 -100.00
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 130,647 120,495 -7.77 2,052 1,913 -6.77
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 144,339 147,109 1.92 2,268 2,336 3.00
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 416,947 307,639 -26.22 6,550 4,885 -25.42
2018-05-11 13F-HR STIFEL FINANCIAL CORP 74,746 96,628 29.28 1,174 1,535 30.75
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 59,295 0 -100.00 932 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 28,015 31,672 13.05 440 503 14.32
2018-05-15 13F-HR UBS Group AG 1,971,486 1,366,566 -30.68 30,972 21,701 -29.93
2018-05-22 13F-HR/A Summit Trail Advisors, Llc 7,000 0 -100.00 110 0 -100.00
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 280 280 0.00 4 4 0.00
2018-05-11 13F-HR LLBH Private Wealth Management, LLC 2,132,674 2,262,603 6.09 33,535 35,930 7.14
2018-05-02 13F-HR WAYNE HUMMER INVESTMENTS L.L.C. 19,707 19,923 1.10 310 316 1.94
2018-05-14 13F-HR DRW Securities, LLC 13,500 0 -100.00 212 0 -100.00
2018-07-18 13F-HR Prospera Financial Services 14,478 15,662 8.18 230 248 7.83
2018-05-11 13F-HR SEI INVESTMENTS CO 3,377 3,377 0.00 53 54 1.89
2018-05-11 13F-HR CITY OF LONDON INVESTMENT MANAGEMENT CO LTD 39,211 39,211 0.00 617 623 0.97
2018-04-17 13F-HR Calton & Associates, Inc. 1,242 0 -100.00 19 0 -100.00
2018-05-15 13F-HR Thomas J. Herzfeld Advisors, Inc. 7,881 5,581 -29.18 124 89 -28.23
2018-05-15 13F-HR Advisor Group, Inc. 21,355 14,409 -32.53 335 229 -31.64
2018-05-15 13F-HR We Are One Seven, Llc 312 0 -100.00 5 0 -100.00
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 2,250 2,550 13.33 35 40 14.29
2018-05-03 13F-HR PINNACLE FINANCIAL PARTNERS INC 16,871 16,871 0.00 265 268 1.13
2018-05-08 13F-HR Penserra Capital Management LLC 0 13,614 0 216
2018-07-06 13F-HR Summit Financial Wealth Advisors, LLC 46,475 46,475 0.00 738 738 0.00
2018-07-16 13F-HR Lenox Wealth Advisors, Inc. 3,000 3,000 0.00 48 47 -2.08
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 327,356 343,290 4.87 5,143 5,451 5.99
2018-05-15 13F-HR Institute for Wealth Management, LLC. 10,619 0 -100.00 166 0 -100.00
2018-05-10 13F-HR Wagner Wealth Management, Llc 129,125 143,210 10.91 2,014 2,274 12.91
2018-05-14 13F-HR MORGAN STANLEY 1,733,181 1,701,760 -1.81 27,228 27,024 -0.75
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 234,000 234,000 0.00 3,716 3,700 -0.43

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Blackstone sees asset base exceeding $500 bln within a year

1h reuters
NEW YORK, July 19 (Reuters) - Blackstone Group LP expects its assets under management (AuM) to exceed half a trillion dollars within the next year, Chairman and Chief Executive Stephen Schwarzman said on Thursday. (14-0)

Blackstone posts 55 pct rise in Q2 earnings per share

6h reuters
NEW YORK (Reuters) - Blackstone Group LP (BX.N), the largest manager of alternative assets such as private equity and real estate, said on Thursday second-quarter earnings per share rose 55 percent from one year ago. (14-1)

Trade-war concerns cloud New York City investment conference

18h reuters
NEW YORK (Reuters) - A prolonged U.S. trade war with China and Europe would dent global economic growth and force investors to reassess the profitability of U.S. companies, some of the biggest hedge funds and private equity investors in the United States warned at an investment conference on Wednesday. (14-0)

Dyal in talks to buy stake in credit manager Golub Capital -sources

2018-07-17 reuters
(Reuters) - Dyal Capital Partners, a subsidiary of asset manager Neuberger Berman Holdings that acquires stakes in private equity firms, is in advanced talks to buy a minority stake in credit investment firm Golub Capital, two people familiar with the matter said. (20-0)

MOVES-Credit Suisse hires Citi's Salas to run fintech banking -memo

2018-07-16 reuters
(Reuters) - Credit Suisse (CSGN.S) has hired Citigroup’s (C.N) Mathieu Salas to head its coverage of financial technology clients, according to an internal memo, the contents of which were confirmed by a spokeswoman for the European bank. (14-0)

CUSIP: 09257R101